Award
Delivery Order #15B31326F00000042
Delivery Order for Medication Supply to FCI Talladega by McKesson Corporation
Buyer
Federal Prison System / Bureau of Prisons
Award Amount
$3,000.00
Ceiling
$3,000.00
Awarded
October 01, 2025
Period of Performance
Oct 01, 2025 – Jan 31, 2026
Identifier
15B31326F00000042
NAICS
325412
This award is a delivery order contract issued under the larger Pharmaceutical Prime Vendor Contract (PPV) indefinite delivery vehicle held by McKesson Corporation, a leading healthcare services and pharmaceutical distribution company. The contract specifically serves the Federal Correctional Institution (FCI) Talladega by supplying Medication-Assisted Treatment (MAT) medications for inmates, aligning with Executive Order 14398. This contract plays a critical role in addressing inmate healthcare within the justice system, ensuring access to essential medications that support rehabilitation and health outcomes. The scope covers the provision and delivery of designated pharmaceuticals to the correctional facility, with performance scheduled over a short-term period spanning several months. Awarded as a task under an existing competitive, multi-year federal contract established by the Department of Veterans Affairs, McKesson leverages its extensive pharmaceutical supply chain capabilities to fulfill this requirement efficiently. The contract's significance extends to promoting continuity of care in correctional settings through timely medication availability. The contract originates from a recent award date and is part of an ongoing series of work within the comprehensive PPV program designed to support healthcare needs across federal agencies.
Description
MAT MEDICATION FOR FCI TALLADEGA INMATES. (IAA-943) "EO 14398"